HIV 1 News and Research

RSS

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.

15 Feb 2013

Xpert diagnosis of TB and its drug resistant strains

The use of a novel, diagnostic test called Xpert is both sensitive and specific in detecting tuberculosis and rifampicin resistance, report US researchers.

14 Feb 2013

Big Pharma looks to Africa for next growth market as economies strengthen, disease burden shifts

"Not only is Africa's economic growth grabbing attention in boardrooms but the shifting nature of its disease burden is luring Big Pharma, as new opportunities open up for treating chronic diseases afflicting the middle classes, rather than just fire-fighting infection," Reuters reports.

13 Feb 2013

Researchers describe novel antiviral property of cholesterol-25-hydroxylase

A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated "priority pathogens" for national biosecurity purposes by the National Institute of Allergy and Infectious Disease.

13 Feb 2013

University of Utah geneticists engineer mice that develop clear cell sarcoma

Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form.

13 Feb 2013

Boston College biologist receives $2.7M NIH grant to continue HIV and AIDS research

Boston College biologist Ken Williams, whose research focuses on the role of immunological cells in a range of illnesses that strike people living with HIV and AIDS, has been awarded a five-year, $2.7 million grant from the NIH's National Institute of Neurological Disorders and Stroke.

12 Feb 2013

Examining efforts to integrate cervical cancer screening, treatment into HIV services in Zambia

In the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Janet Fleischman and Julia Nagel of CSIS discuss "the opportunities and challenges of integrating cervical cancer screening and treatment into HIV services for women," with a focus on the efforts of Zambia.

12 Feb 2013

Viewpoints: Contraceptive debate may hinge on 'conscience of a corporation;' Rep. Cantor's insights on Medicare; Sebelius and holder on fraud

Today, our departments released a report showing that the Obama Administration's historic efforts to go after criminals who steal from Medicare and Medicaid are paying off, especially in hotspots like Houston. The report shows that last year, we recovered a record $4.2 billion from those who prey on our health care system. In total, our efforts returned $14.9 billion over the last four years, more than double what was returned in the previous four years.

11 Feb 2013

Oral Candida infection weakens tooth enamel

Oral infection with Candida albicans is associated with demineralization of tooth enamel, potentially increasing susceptibility to caries, research shows.

11 Feb 2013

APOBEC3B enzyme plays a key role in breast cancer

Researchers at the University of Minnesota have uncovered a human enzyme responsible for causing DNA mutations found in the majority of breast cancers. The discovery of this enzyme - called APOBEC3B - may change the way breast cancer is diagnosed and treated.

10 Feb 2013

Tat-beclin 1 shows promise against infections, neurodegenerative disorders and cancer

UT Southwestern Medical Center scientists have synthesized a peptide that shows potential for pharmaceutical development into agents for treating infections, neurodegenerative disorders, and cancer through an ability to induce a cell-recycling process called autophagy.

10 Feb 2013

Zimbabwe faces challenges in preventing, treating cervical cancer, PlusNews reports

"HIV-positive women are living longer, but are now dying of cervical cancer," and "[i]n Zimbabwe, cervical cancer is now the most common cancer among women, particularly those living with HIV," PlusNews reports.

10 Feb 2013

Advocates come together to mobilize resources for Global Fund to fight AIDS, TB, malaria

"Over the last two weeks, a series of meetings were held in Amsterdam in the Netherlands -- advocates and people from the communities affected by HIV/AIDS, tuberculosis [TB] and malaria came together to strategize and decide on courses of action to take in this critical year of replenishing the Global Fund to Fight AIDS, Tuberculosis and Malaria," Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, writes in the Huffington Post's "Impact" blog.

10 Feb 2013

HIV 1 News and Research

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

Xpert diagnosis of TB and its drug resistant strains

Big Pharma looks to Africa for next growth market as economies strengthen, disease burden shifts

Researchers describe novel antiviral property of cholesterol-25-hydroxylase

University of Utah geneticists engineer mice that develop clear cell sarcoma

Boston College biologist receives $2.7M NIH grant to continue HIV and AIDS research

Examining efforts to integrate cervical cancer screening, treatment into HIV services in Zambia

Viewpoints: Contraceptive debate may hinge on 'conscience of a corporation;' Rep. Cantor's insights on Medicare; Sebelius and holder on fraud

Oral Candida infection weakens tooth enamel

APOBEC3B enzyme plays a key role in breast cancer

Tat-beclin 1 shows promise against infections, neurodegenerative disorders and cancer

Zimbabwe faces challenges in preventing, treating cervical cancer, PlusNews reports

Advocates come together to mobilize resources for Global Fund to fight AIDS, TB, malaria

Social networking sites could effectively help prevent HIV infection among at-risk groups

HIV prevention: don’t just target serodiscordant couples

First new TB vaccine in century fails initial testing

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Extra-couple relationships one of the main drivers of the HIV epidemic in sub-Saharan Africa

Experimental TB vaccine does not protect infants, study shows

Boston College biologist to explore connection between peripheral neuropathy and HIV

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News